海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
195件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A randomized, placebo-controlled study investigating the effects of moxaverine on ocular blood flow after oral administration in healthy subjects - MOXOPH3
- healthy subjects MedDRA version: 12.1 Level: LLT Classification code 10038881 Term: Retinal microcirculation disorder MedDRA version: 12.1 Level: HLT Classification code 10030067 Term: Ocular vascular disorders NEC
- Austria
- 2010-04-08
Not Recruiting
- Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects - Pioglitazone
- There is an association between insulin resistance and endothelial dysfunction which is thought to be a critical factor in the development of vascular disease and thus an important factor in the development of atherosclerosis, hypertension and heart failure. Endothelial dysfunction can occur even in the vascular absence of angiographically defined disease and can be detected early in the spectrum of insulin resistance.
- Austria
- 2005-04-05
Not recruiting
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients
- Hepatitis B, Chronic;Hepatitis B, Chronic;Hepatitis B, Chronic;Hepatitis B, Chronic
- Hong Kong, New Zealand, Taiwan
- 2015-11-10
Not recruiting
- Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
- Mycobacterium Infections, Nontuberculous;Mycobacterium Infections, Nontuberculous;Mycobacterium Infections, Nontuberculous
- Australia, Austria, Canada, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Sweden, Taiwan, Thailand, United Kingdom, United States
- 2015-01-09
Not recruiting
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes
- Diabetes Mellitus
- Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, Switzerland, United Kingdom
- 2005-09-09
Not recruiting
- Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects
- Chronic Hepatitis C
- Austria, Poland
- 2011-10-23
Not Recruiting
- UVA 1 therapy versus 5-MOP UVA photochemotherapy for patients with severe generalized atopic dermatitis - UVA 1 vs 5-MOP UVA for AD
- Severe generalized atopic dermatitis MedDRA version: 9.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis
- Austria
- 2007-03-14
Not recruiting
- Oral Administration of Four Lactobacillus Species Preparation to Improve the Quality of the Neovaginal Flora in Male to Female Transsexual Patients
- Reduction or Absence of Lactobacilli in Neovaginal Flora
- Austria
- 2012-10-11
Not Recruiting
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP640 (PVP-IODINE 0.6% AND DEXAMETHASONE 0.1%) OPHTHALMIC SUSPENSION COMPARED TO PVP-IODINE AND PLACEBO IN THE TREATMENT OF ADENOVIRAL CONJUNCTIVITIS.
- -B301 +Conjunctivitis due to adenovirus (H13.1*) +Conjunctivitis due to adenovirus (H13.1*);+Conjunctivitis due to adenovirus (H13.1*)
- Australia, Austria, Canada, Colombia, Estonia, France, Germany, Hungary, India, Israel, Italy, Philippines, Poland, South Africa, Spain, United Kindgdom, United States
- 2018-08-13
Not Recruiting
- A randomised, double-blind, placebo controlled, parallel group 24 week study to assess the efficacy and safety of BI 1356 (5 mg) in combination with 30 mg pioglitazone (both administered orally once daily), compared to 30 mg pioglitazone plus placebo in drug naive or previously treated type 2 diabetic patients with insufficient glycaemic control. - Efficacy vs. PBO as initial combination therapy with pioglitazone
- Patients with type 2 Diabetes Mellitus with insufficient glycaemic control. MedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus
- Austria, Greece, Hungary, Portugal, Spain
- 2008-01-22